Rajasthan Antibiotics gets closer to its consolidation plan of merging its group companies for obtaining a greater asset base and consolidation of its pharmaceutical business. Dhir & Dhir Associates successfully represented the Company in its first motion petition wherein the Special Bench, NCLT, while hearing the matter through video conferencing, allowed the first motion application and granted an exemption to the Company from convening meetings as shareholders and creditors.